Roman Butler Fullerton & CO Corcept Therapeutics Inc Transaction History
Roman Butler Fullerton & CO
- $261 Million
- Q1 2025
A detailed history of Roman Butler Fullerton & CO transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Roman Butler Fullerton & CO holds 3,354 shares of CORT stock, worth $263,926. This represents 0.15% of its overall portfolio holdings.
Number of Shares
3,354
Previous 26,497
87.34%
Holding current value
$263,926
Previous $1.34 Million
71.31%
% of portfolio
0.15%
Previous 0.39%
Shares
5 transactions
Others Institutions Holding CORT
# of Institutions
477Shares Held
84MCall Options Held
1.43MPut Options Held
2.75M-
Black Rock Inc. New York, NY16.5MShares$1.3 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.98MShares$785 Million0.02% of portfolio
-
Ingalls & Snyder LLC New York, NY7.74MShares$609 Million29.09% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.14MShares$483 Million1.13% of portfolio
-
Parallel Advisors, LLC3.97MShares$313 Million5.04% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $8.43B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...